Target intelligence / Profile preview

Mitochondrial oxidative damage

01

Overview

Mitochondrial oxidative damage is not a discrete molecule or receptor, but refers to the cellular injury resulting from excess ROS generated by the mitochondrial electron transport chain, particularly at complexes I and III, overwhelming native antioxidant defenses. This process causes modification and degradation of mitochondrial DNA, proteins, and lipids, leading to loss of mitochondrial function, impairment of ATP production, activation of cell death pathways, and is implicated as a central driver in aging, neurodegenerative conditions, cardiovascular disorders, cancer, and other pathologies. Therapeutic strategies often aim at scavenging mitochondrial ROS or boosting mitochondrial antioxidant defenses, though clinical efficacy remains limited due to biological complexity.

Other names
mitochondrial oxidative stressmitochondrial ROS damageoxidative mitochondrial injury
02

Mechanism of action

Reduction of mitochondrial ROS formation Enhancement of mitochondrial antioxidant capacity Prevention of oxidative biomolecule damage

03

Biological functions

Cell death (apoptosis/necrosis)Impairment of mitochondrial bioenergeticsDNA/protein/lipid damageDisruption of calcium homeostasisInduction of aging processPromotion of programmed cell death
04

Disease associations

Neurodegenerative disease (Alzheimer's, Parkinson's, ALS)CancerCardiovascular diseaseAgingInflammation
05

Safety considerations

Non-specificity of antioxidants leading to systemic effectsLimited efficacy in clinical trials for age-related diseasesRisk of interfering with physiological ROS signalingPotential toxicity from long-term antioxidant use
06

Interacting drugs

Mitochondria-targeted antioxidants (e.g. MitoQ, SS-peptides)

1 more in the full profile.

07

Biomarkers

8-oxo-dG (oxidative DNA lesion in mtDNA)Protein carbonylsMutations/deletions in mitochondrial DNACytochrome c oxidase levels

Beyond the preview

Go deeper on Mitochondrial oxidative damage.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial oxidative damage.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call